CAPÍTULO4
1. J. Mendels, J. L. Stinnett, D. D. Burns y A. Frazer, «Amine Precursors and Depression», Archives of
General Psychiatry 32, 1975, págs. 22-30.
2. Hypericum Depression Trial Study Group, «Effect of Hypericum Perforatum (St. John’s Wort) in Ma-
jor Depressive Disorder: A Randomized, Controlled Trial», Journal of the American Medical Association,
nº 287, 2002, págs. 1.807-1.814. Resumen: <http://www.nih.gov/news/pr/apr2002/nccam-09.htm>.
3. I. Kirsch y G. Sapirstein, «Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepres-
sant Medication», Prevention and Treatment, nº 1, 1998, artículo 0002a. Accesible en <http://journals.
apa.org/prevention/volume1/pre0010002a.html>.
I. Kirsch, T. J. Moore, A. Scoboria y S. S. Nicholls, «The Emperor’s New Drugs: An Analysis of Antide-
pressant Medication Data Submitted to the U.S. Food and Drug Administration», Prevention and Treatment,
nº 5, 2002, artículo 23. Accesible en <http://journals.apa.org/prevention/volume5/pre0050023a. html>.
4. S. H. Preskorn, «Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors: An
Overview with Emphasis on Pharmacokinetics and Effects on Oxidative Drug Metabolism», Clinical Phar-
macokinetics, nº 32, supl. 1, 1997, págs. 1-21.
I. Kirsch y G. Sapirstein, «Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant
Medication», Prevention and Treatment, nº 1, 1998, artículo 0002a. Accesible en <http://journals.apa.org/
prevention/volume1/pre0010002a.html>.
I. Kirsch, T. J. Moore, A. Scoboria y S. S. Nicholls, «The Emperor’s New Drugs: An Analysis of Antide-
pressant Medication Data Submitted to the U.S. Food and Drug Administration», Prevention and Treatment,
nº 5, 2002, artículo 23. Accesible en <http://journals.apa.org/prevention/volume5/pre0050023a. html>.
5. D. O. Antonuccio, W. G. Danton y G. Y. DeNelsky, «Psychotherapy versus Medication for Depression:
Challenging the Conventional Wisdom with Data», Professional Psychology: Research and Practice, nº 26,
1995, págs. 574-585.
D. O. Antonuccio, W. G. Danton, G. Y. DeNelsky, R. Greenberg y J. S. Gordon, «Raising Questions about
Antidepressants», Psychotherapy and Psychosomatics, nº 68, 1999, págs. 3-14.
D. O. Antonuccio, D. Burns y W. G. Danton, «Antidepressants: A Triumph of Marketing over Science?»,
Prevention and Treatment, nº 5, 2002, artículo 25. Accesible en <http://journals.apa.org/prevention/volu-
me5/toc-jul15-02.htm>.
6. E. J. Garland, «Facing the Evidence: Antidepressant Treatment in Children and Adolescents», Cana-
dian Medical Association Journal, nº 170, 2004, págs. 489-491.
N. Jureidini, C. J. Doecke, P. R. Mansfield, M. M. Haby, D. B. Menkes y A. L. Tonkin, «Efficacy and
Safety of Antidepressants in Children and Adolescents», British Medical Journal, nº 328, 2004, págs. 879-
883.
C. J. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Colgrove y E. Boddington, «Selective Serotonin
Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data»,
Lancet, nº 363, 2004, págs. 1.341-1.345.
7. D. Healy, «Lines of Evidence on the Risk of Suicide with Selective Serotonin Reuptake Inhibitors»,
Psychotherapy and Psychosomatics, nº 72, 2003, págs. 71-79.
8. H. A. Westra y S. H. Stewart, «Cognitive Behavioral Therapy and Pharmacotherapy: Complementary
or Contradictory Approaches to the Treatment of Anxiety?», Clinical Psychology Review, vol. 18, nº 3, 1998,
págs. 307-340.
9. D. O. Antonuccio, W. G. Danton y G. Y. DeNelsky, «Psychotherapy versus Medication for Depression:
Challenging the Conventional Wisdom with Data», Professional Psychology: Research and Practice, nº 26,
1995, págs. 574-585.
10. R. J. DeRubeis, S. D. Hollon, J. D. Amsterdam, R. C. Shelton, P. R. Young, R. M. Salomon, J. P.
O’Reardon, M. L. Lovett, M. M. Gladis, L. L. Brown y R. Gallop, «Cognitive Therapy vs. Medications in the
Treatment of Moderate to Severe Depression», Archives of General Psychiatry, nº 62, 2005, págs. 409-416.
Resumen: <http://archpsych.ama-assn.org/cgi/content/abstract/62/4/409>.
S. D. Hollon, R. J. DeRubeis, R. C. Shelton, J. D. Amsterdam, R. M. Salomon, J. P. O’Reardon, M. L. Lo-
vett, P. R. Young, K. L. Haman, B. B. Freeman y R. Gallop, «Prevention of Relapse Following Cognitive